Cargando…

Patterns of Failure in Patients With Head and Neck Squamous Cell Carcinomas of Unknown Primary Treated With Chemoradiotherapy

BACKGROUND: To evaluate the patterns of failure in patients treated for head and neck carcinoma of unknown primary and to discuss treatment practices concerning radiotherapy target volumes definition and dose prescription. METHODS: Eleven patients presenting a locoregional recurrence after head and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dhouib, Fatma, Bertaut, Aurélie, Maingon, Philippe, Siala, Wicem, Daoud, Jamel, Aubignac, Léone, Lestrade, Laetitia, Crehange, Gilles, Vulquin, Noemie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7268107/ https://www.ncbi.nlm.nih.gov/pubmed/32484037 http://dx.doi.org/10.1177/1533033820905826

Ejemplares similares

Impact of waiting time on nodal staging in head and neck squamous-cell carcinoma treated with radical intensity modulated radiotherapy
por: Chevalier, Cédric, et al.
Publicado: (2016)

Hypofractionated Stereotactic Radiotherapy as a Salvage Therapy for Recurrent High-Grade Gliomas: Single-Center Experience
por: Reynaud, Thomas, et al.
Publicado: (2018)

Online adaptive radiotherapy and dose delivery accuracy: A retrospective analysis
por: Bessieres, Igor, et al.
Publicado: (2023)

Randomized Trial Assessing the Impact of Routine Assessment of Health-Related Quality of Life in Patients with Head and Neck Cancer
por: Billa, Oumar, et al.
Publicado: (2021)

Patterns of Bone Failure in Localized Prostate Cancer Previously Irradiated: The Preventive Role of External Radiotherapy on Pelvic Bone Metastases
por: Grapin, Mathieu, et al.
Publicado: (2019)

PO-1517 Which impact of the COVID-19 pandemic on residents training in radiotherapy?
por: Fourati, N., et al.
Publicado: (2021)

Does gap-free intensity modulated chemoradiation therapy provide a greater clinical benefit than 3D conformal chemoradiation in patients with anal cancer?
por: Dewas, Claire Vautravers, et al.
Publicado: (2012)

Impact of Neck Dissection in Head and Neck Squamous Cell Carcinomas of Unknown Primary
por: Abu-Shama, Yazan, et al.
Publicado: (2021)

PO-1059 The contribution of hypofractionated radiotherapy during the COVID 19 pandemic
por: Dhouib, F., et al.
Publicado: (2022)

Squamous cell carcinoma metastatic to cervical lymph nodes from unknown primary origin: the impact of chemoradiotherapy
por: Eldeeb, Hany, et al.
Publicado: (2012)

Treatment outcomes of unknown primary squamous cell carcinoma of the head and neck
por: Hung, Yu-Hsuan, et al.
Publicado: (2018)

Combined Nimotuzumab with Chemoradiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma
por: Thai Hoa, Nguyen Thi, et al.
Publicado: (2020)

Treatment Outcomes of Patients with Head and Neck Squamous Cell Carcinoma of Unknown Primary
por: Park, Kyeong Suk, et al.
Publicado: (2021)

Exclusive image guided IMRT vs. radical prostatectomy followed by postoperative IMRT for localized prostate cancer: a matched-pair analysis based on risk-groups
por: Azelie, Caroline, et al.
Publicado: (2012)

Stereotactic Body radiation therapy for liver tumors with or without rotational intensity modulated radiation therapy
por: Nouhaud, Elodie, et al.
Publicado: (2013)

Absolute volume of the rectum and AUC from rectal DVH between 25Gy and 50Gy predict acute gastrointestinal toxicity with IG-IMRT in prostate cancer
por: Mirjolet, Céline, et al.
Publicado: (2016)

Induction chemotherapy with concurrent chemoradiotherapy versus concurrent chemoradiotherapy for locally advanced squamous cell carcinoma of head and neck: a meta-analysis
por: Zhang, Lijuan, et al.
Publicado: (2015)

Prediction of prostate cancer recurrence after radiation therapy using multiparametric magnetic resonance imaging and spectroscopy: assessment of prognostic factors on pretreatment imaging
por: Asuncion, Audrey, et al.
Publicado: (2022)

Chemoradiotherapy for Head and Neck Cancer
por: D’Onofrio, Ida, et al.
Publicado: (2023)

Predictors for Survival of Patients with Squamous Cell Carcinoma of Unknown Primary in the Head and Neck Region
por: Wagner, Steffen, et al.
Publicado: (2023)

Lymph node reactivity and microvessel density in neck metastases of unknown primary squamous cell carcinoma
por: Amar, Ali, et al.
Publicado: (2015)

Evaluation of QA software system analysis for the static picket fence test
por: Boudet, Julien, et al.
Publicado: (2022)

Evaluation of the quality of life of patients before treatment of squamous cell carcinoma of the head and neck by means of chemoradiotherapy
por: Visacri, Marília Berlofa, et al.
Publicado: (2015)

Volumetric PET/CT parameters predict local response of head and neck squamous cell carcinoma to chemoradiotherapy
por: Hanamoto, Atsushi, et al.
Publicado: (2014)

Concurrent Chemoradiotherapy With Weekly Low-Dose Cisplatin for Japanese Patients With Head and Neck Squamous Cell Carcinoma
por: Shinohara, Shogo, et al.
Publicado: (2021)

Concurrent chemoradiotherapy using gemcitabine and nedaplatin in recurrent or locally advanced head and neck squamous cell carcinoma
por: Huo, Rui-Xue, et al.
Publicado: (2022)

The Utility of Ultrasonography in the Diagnosis of Cervical Lymph Nodes after Chemoradiotherapy for Head and Neck Squamous Cell Carcinoma
por: Terada, Hoshino, et al.
Publicado: (2021)

Characterization of the Immune Response to PD-1 Blockade during Chemoradiotherapy for Head and Neck Squamous Cell Carcinoma
por: Callejas-Valera, Juan L., et al.
Publicado: (2022)

Optimized fractionated radiotherapy with anti-PD-L1 and anti-TIGIT: a promising new combination
por: Grapin, Mathieu, et al.
Publicado: (2019)

Transoral Laser Resection of the Tongue Base in the Workup of Unknown Primary Head and Neck Squamous Cell Carcinoma
por: Chan, Sarah P, et al.
Publicado: (2023)

Nutrition Support for Head and Neck Squamous Cell Carcinoma Patients Treated with Chemoradiotherapy: How Often and How Long?
por: Ishiki, Hiroto, et al.
Publicado: (2012)

Tumor Infiltrating Lymphocytes are Prognostic Factors and Can Be Markers of Sensitivity to Chemoradiotherapy in Head and Neck Squamous Cell Carcinoma
por: Suzuki, Hitomi, et al.
Publicado: (2022)

Significance of the Neutrophil-to-Lymphocyte Ratio in p16-Negative Squamous Cell Carcinoma of Unknown Primary in Head and Neck
por: Xu, Chunmiao, et al.
Publicado: (2020)

Squamous cell carcinoma of the head and neck with unknown primary: trends and outcomes from a hospital-based registry
por: Cummings, Michael A., et al.
Publicado: (2021)

In-vivo and in-vitro impact of high-dose rate radiotherapy using flattening-filter-free beams on the anti-tumor immune response
por: Laurent, P.A., et al.
Publicado: (2020)

Phase II study of concurrent chemoradiotherapy with capecitabine and cisplatin in patients with locally advanced squamous cell carcinoma of the head and neck
por: Kim, J G, et al.
Publicado: (2005)

Comparison of Carboplatin With 5-Fluorouracil vs. Cisplatin as Concomitant Chemoradiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma
por: Hanemaaijer, Saskia H., et al.
Publicado: (2020)

Ovarian cancer‐derived copy number alterations signatures are prognostic in chemoradiotherapy‐treated head and neck squamous cell carcinoma
por: Essers, Paul B.M., et al.
Publicado: (2020)

Changes in Gene Expression Patterns in the Tumor Microenvironment of Head and Neck Squamous Cell Carcinoma Under Chemoradiotherapy Depend on Response
por: Doescher, Johannes, et al.
Publicado: (2022)

Updates in the management of unknown primary of the head and neck
por: Kalavacherla, Sandhya, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_724r8fre6houf4pkfppnb0a80o